Survival of Filipino women with breast cancer in the United States
Cancer Medicine · 2023
DOI: 10.1002/cam4.6403 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2023. Verfasst von David W Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.
Abstract (Originalsprache)
Background
The survival of women with early‐stage breast cancer varies by racial group. Filipino women with breast cancer are an understudied group and are often combined with other Asian groups. We compared clinical presentations and survival rates for Filipino and White women with breast cancer diagnosed in the United States.
Methods
We conducted a retrospective cohort study of women with breast cancer diagnosed between 2004 and 2015 in the SEER18 registries database. We compared crude survival between Filipino and White women. We then calculated adjusted hazard ratios (HR) in a propensity‐matched design using the Cox proportional hazards model.
Results
There were 10,834 Filipino (2.5%) and 414,618 White women (97.5%) with Stage I–IV breast cancer in the SEER database. The mean age at diagnosis was 57.5 years for Filipino women and 60.8 years for White women ( p < 0.0001). Filipino women had more high‐grade and larger tumors than White women and were more likely to have node‐positive disease. Among women with Stage I–IIIC breast cancer, the crude 10‐year breast cancer‐specific survival rate was 91.0% for Filipino and 88.9% for White women (HR 0.81, 95% CI 0.74–0.88, p < 0.01). In a propensity‐matched analysis, the HR was 0.73 (95% CI 0.66–0.81). The survival advantage for Filipino women was present in subgroups defined by age of diagnosis, nodal status, estrogen receptor status, and HER2 receptor status.
Conclusion
In the United States, Filipino women often present with more advanced breast cancers than White women, but experience better breast cancer‐specific survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
- Department of Surgery, Women's College Hospital, Toronto, Ontario, Canada.
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- Division of General Surgery, University Health Network (Princess Margaret Cancer Centre), Toronto, Ontario, Canada.
ORCID-Profile: David W Lim, Steven A Narod
Förderung
- CIHR
Zitieren
APA
Lim, D. W., Li, W. W., Giannakeas, V., Cil, T. D., & Narod, S. A. (2023). Survival of Filipino women with breast cancer in the United States. Cancer Medicine. https://doi.org/10.1002/cam4.6403
Vancouver
Lim DW, Li WW, Giannakeas V, Cil TD, Narod SA. Survival of Filipino women with breast cancer in the United States. Cancer Medicine. 2023. doi:10.1002/cam4.6403
BibTeX
@article{Lim2023,
author = {Lim, David W and Li, Winston W and Giannakeas, Vasily and Cil, Tulin D and Narod, Steven A},
title = {Survival of Filipino women with breast cancer in the United States},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6403}
}
EUVIMED